Symbravo Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Symbravo (meloxicam and rizatriptan) for migraines and are having trouble filling your prescription, you may be wondering: is Symbravo in a drug shortage? The short answer: No — Symbravo is not on the FDA's official drug shortage list. But that doesn't mean it's easy to find. Here's what's actually going on and what you can do about it.

Symbravo Shortage Status in 2026: The Official Answer

As of 2026, Symbravo does NOT appear on the FDA Drug Shortage Database or the ASHP (American Society of Health-System Pharmacists) shortage list. Axsome Therapeutics, the manufacturer, has not announced any supply disruptions. There is no national shortage in the traditional sense — meaning there is no manufacturing failure, recall, or supply chain breakdown affecting the drug's overall supply.

So Why Can't Patients Find Symbravo at Their Pharmacy?

Symbravo was FDA-approved on January 30, 2025 — making it one of the newest prescription medications on the market. New drugs face unique distribution challenges that can look and feel like a shortage from the patient's perspective, even when there technically isn't one. Here's why:

Reason 1: Distribution Is Still Ramping Up

When a new brand-name drug launches, it takes months — sometimes more than a year — for it to be stocked routinely at pharmacies across the country. Wholesalers build inventory based on projected demand, and pharmacies order based on local prescribing patterns. Because Symbravo is new, many pharmacies haven't experienced enough patient requests to justify keeping it in stock. The result: you often need to call several pharmacies or have your prescription specially ordered.

Reason 2: Limited Insurance Coverage Suppresses Demand

Insurance coverage dramatically shapes what pharmacies stock. When a drug isn't covered by most plans, fewer patients end up filling it — which signals to pharmacies that demand is low. Here's where Symbravo stands on coverage:

Most Medicare Part D plans do not cover Symbravo

Commercial and ACA plan coverage is limited and often requires prior authorization or step therapy

Most Medicaid plans cover it, but typically require prior authorization

The combination of high cash price (roughly $1,300–$1,420 for 9 tablets) and limited insurance coverage means many patients either don't fill Symbravo at all or abandon the prescription at the counter — reducing the pharmacy stocking incentive.

Reason 3: No Generic Exists Yet

Generic drugs dominate pharmacy shelves because they're prescribed far more frequently and at lower prices. Symbravo, as a brand-new drug, has no generic and won't for years. Pharmacies that are already stretched on shelf space and inventory capital may deprioritize stocking a low-volume brand-name medication. This isn't a shortage — it's a market reality of new drug launches.

Is Symbravo Availability Improving?

Yes. As Symbravo builds a prescription track record and more neurologists, headache specialists, and primary care providers adopt it, pharmacy stocking is gradually improving. Axsome Therapeutics has been actively working to expand access through its sales force and through patient savings programs. Larger chain pharmacies — CVS, Walgreens, Walmart Pharmacy — are increasingly able to fill Symbravo prescriptions, especially with advance notice. Availability will continue to improve through 2026 and beyond as the drug becomes more established.

What Should Patients Do Right Now?

Here are the steps that give you the best chance of filling your Symbravo prescription in 2026:

Use medfinder: medfinder calls pharmacies in your area to check stock, so you don't have to do it yourself.

Check large chain pharmacies first: CVS, Walgreens, Walmart Pharmacy, and Kroger are most likely to have or be able to quickly order Symbravo.

Ask for a special order: Many pharmacies can receive Symbravo within 1–2 business days if ordered from their wholesaler.

Use the savings program: Commercially insured patients can call 866-496-2976 for the Symbravo On My Side Savings Program — as little as $10 out of pocket for up to a 90-day supply.

Ask your doctor about samples: Neurologists and headache specialists may have physician samples available.

Consider alternatives: If Symbravo simply isn't accessible for you right now, read about alternatives to Symbravo to discuss with your prescriber.

The Bottom Line for Patients

Symbravo is not in a formal drug shortage in 2026. The challenge patients face is the natural friction of a newly launched brand-name drug finding its footing in the pharmacy marketplace. Availability is improving, and the tools and programs above give you the best chance of filling your prescription. Stay persistent — and don't assume your next pharmacy will have the same answer as the last one.